Our portfolio
Focused by design.
A clear view of Ribicon Pharma’s current areas of focus. Detailed product information is provided only after appropriate regulatory and medical review.
Diagnostics
Solid-Tumor Biomarkers
A focused portfolio of biomarkers associated with solid-tumor detection and monitoring.
Specialty medicines
Targeted Therapeutics
Specialized therapies presented for healthcare-professional and institutional audiences.
Eye health
Ophthalmology
A concise ophthalmology portfolio for the management of intraocular pressure.
Cardiac diagnostics
Cardiology
Diagnostic tools and tests supporting timely cardiovascular assessment.
Portfolio in development
Veterinary Diagnostics
A future diagnostic biomarker portfolio. Product information will be published after review.
Information forthcomingProduct names, intended uses, and supporting documentation will be added after the portfolio is confirmed.
Portfolio in development
Infant Formulas & Children’s Food
A future range of infant formulas and children’s food. Product information will be published after review.
Information forthcomingProduct names, intended uses, and supporting documentation will be added after the portfolio is confirmed.
For healthcare professionals
Need verified product information?
Contact Ribicon Pharma for current product status, approved Canadian product documentation, and medical information. Public portfolio descriptions are not a substitute for an authorized product monograph or professional advice.
Request product information